ID   GLT15_HUMAN             Reviewed;         639 AA.
AC   Q8N3T1; A6NMN1; B2R638; F1LIP6; Q86T60; Q96C46; Q96DJ5;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 2.
DT   03-AUG-2022, entry version 158.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 15;
DE            EC=2.4.1.41 {ECO:0000269|PubMed:15147861};
DE   AltName: Full=Polypeptide GalNAc transferase-like protein 2;
DE            Short=GalNAc-T-like protein 2;
DE            Short=pp-GaNTase-like protein 2;
DE   AltName: Full=Polypeptide N-acetylgalactosaminyltransferase-like protein 2;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase-like protein 2;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2;
GN   Name=GALNT15; Synonyms=GALNTL2; ORFNames=UNQ770/PRO1564;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=15147861; DOI=10.1016/j.febslet.2004.03.108;
RA   Cheng L., Tachibana K., Iwasaki H., Kameyama A., Zhang Y., Kubota T.,
RA   Hiruma T., Tachibana K., Kudo T., Guo J.-M., Narimatsu H.;
RT   "Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T15.";
RL   FEBS Lett. 566:17-24(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Osteoarthritic cartilage;
RX   PubMed=11597177; DOI=10.1053/joca.2001.0421;
RA   Kumar S., Connor J.R., Dodds R.A., Halsey W., Van Horn M., Mao J.,
RA   Sathe G.M., Mui P., Agarwal P., Badger A.M., Lee J.C., Gowen M., Lark M.W.;
RT   "Identification and initial characterization of 5000 expressed sequenced
RT   tags (ESTs) each from adult human normal and osteoarthritic cartilage cDNA
RT   libraries.";
RL   Osteoarthritis Cartilage 9:641-653(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-432.
RC   TISSUE=Adipose tissue, and Spinal cord;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT THR-432.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide
CC       biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a
CC       serine or threonine residue on the protein receptor. Although it
CC       displays a much weaker activity toward all substrates tested compared
CC       to GALNT2, it is able to transfer up to seven GalNAc residues to the
CC       Muc5AC peptide, suggesting that it can fill vicinal Thr/Ser residues in
CC       cooperation with other GALNT proteins. Prefers Muc1a as substrate.
CC       {ECO:0000269|PubMed:15147861}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-O-
CC         [N-acetyl-alpha-D-galactosaminyl]-L-seryl-[protein] + H(+) + UDP;
CC         Xref=Rhea:RHEA:23956, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12788,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:53604,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:67138; EC=2.4.1.41;
CC         Evidence={ECO:0000269|PubMed:15147861};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonyl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-
CC         O-[N-acetyl-alpha-D-galactosaminyl]-L-threonyl-[protein] + H(+) +
CC         UDP; Xref=Rhea:RHEA:52424, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11689, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:67138, ChEBI:CHEBI:87075; EC=2.4.1.41;
CC         Evidence={ECO:0000269|PubMed:15147861};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- INTERACTION:
CC       Q8N3T1; Q8TD46-4: CD200R1; NbExp=3; IntAct=EBI-3925203, EBI-12824513;
CC       Q8N3T1; P11912: CD79A; NbExp=3; IntAct=EBI-3925203, EBI-7797864;
CC       Q8N3T1; Q8N5K1: CISD2; NbExp=3; IntAct=EBI-3925203, EBI-1045797;
CC       Q8N3T1; P34910-2: EVI2B; NbExp=3; IntAct=EBI-3925203, EBI-17640610;
CC       Q8N3T1; Q6DN72: FCRL6; NbExp=3; IntAct=EBI-3925203, EBI-23889796;
CC       Q8N3T1; O15552: FFAR2; NbExp=3; IntAct=EBI-3925203, EBI-2833872;
CC       Q8N3T1; Q8TBE3: FNDC9; NbExp=3; IntAct=EBI-3925203, EBI-12142257;
CC       Q8N3T1; Q8NBJ4: GOLM1; NbExp=3; IntAct=EBI-3925203, EBI-712073;
CC       Q8N3T1; Q6UWB1: IL27RA; NbExp=3; IntAct=EBI-3925203, EBI-19045531;
CC       Q8N3T1; Q95460-2: MR1; NbExp=3; IntAct=EBI-3925203, EBI-12201447;
CC       Q8N3T1; Q9BQ51: PDCD1LG2; NbExp=3; IntAct=EBI-3925203, EBI-16427978;
CC       Q8N3T1; Q13113: PDZK1IP1; NbExp=3; IntAct=EBI-3925203, EBI-716063;
CC       Q8N3T1; Q9BRI3: SLC30A2; NbExp=5; IntAct=EBI-3925203, EBI-8644112;
CC       Q8N3T1; P30825: SLC7A1; NbExp=3; IntAct=EBI-3925203, EBI-4289564;
CC       Q8N3T1; Q8TBG9: SYNPR; NbExp=3; IntAct=EBI-3925203, EBI-10273251;
CC       Q8N3T1; Q7Z7N9: TMEM179B; NbExp=3; IntAct=EBI-3925203, EBI-11724423;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-
CC       pass type II membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in small
CC       intestine, placenta, spleen, cerebral cortex and ovary. Expressed at
CC       intermediate level in uterus, mammary gland, stomach, cerebellum and
CC       whole brain. Weakly expressed in fetal brain, bone marrow, thyroid
CC       gland, thymus, heart, skeletal muscle, lung, liver, colon, pancreas,
CC       kidney and testis. Not expressed in leukocyte. Expressed in both normal
CC       and osteoarthritic cartilage. Expressed at low level in chondrocytes in
CC       all zones of both normal and osteoarthritic cartilage.
CC       {ECO:0000269|PubMed:11597177, ECO:0000269|PubMed:15147861}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif), which
CC       is probably involved in manganese coordination and substrate binding
CC       and the C-terminal domain (domain B, also called Gal/GalNAc-T motif),
CC       which is probably involved in catalytic reaction and UDP-Gal binding.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and contributes
CC       to the glycopeptide specificity. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- CAUTION: Was originally termed Galnt15/pp-GaNTase 15.
CC       {ECO:0000305|PubMed:15147861}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD89983.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Polypeptide N-acetylgalactosaminyltransferase-like protein 2;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_501";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB078149; BAD29961.1; -; mRNA.
DR   EMBL; AY035399; AAK63127.1; -; mRNA.
DR   EMBL; AY358443; AAQ88808.1; -; mRNA.
DR   EMBL; AK312425; BAG35335.1; -; mRNA.
DR   EMBL; AL831925; CAD38585.1; -; mRNA.
DR   EMBL; AL832575; CAD89983.1; ALT_FRAME; mRNA.
DR   EMBL; AC087858; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64266.1; -; Genomic_DNA.
DR   EMBL; BC014789; AAH14789.1; -; mRNA.
DR   CCDS; CCDS33711.1; -.
DR   RefSeq; NP_473451.3; NM_054110.4.
DR   AlphaFoldDB; Q8N3T1; -.
DR   SMR; Q8N3T1; -.
DR   BioGRID; 125583; 18.
DR   IntAct; Q8N3T1; 17.
DR   STRING; 9606.ENSP00000344260; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   GlyGen; Q8N3T1; 2 sites.
DR   PhosphoSitePlus; Q8N3T1; -.
DR   BioMuta; GALNT15; -.
DR   DMDM; 51316023; -.
DR   EPD; Q8N3T1; -.
DR   MassIVE; Q8N3T1; -.
DR   PaxDb; Q8N3T1; -.
DR   PeptideAtlas; Q8N3T1; -.
DR   PRIDE; Q8N3T1; -.
DR   ProteomicsDB; 71833; -.
DR   Antibodypedia; 2430; 71 antibodies from 18 providers.
DR   DNASU; 117248; -.
DR   Ensembl; ENST00000339732.10; ENSP00000344260.5; ENSG00000131386.20.
DR   GeneID; 117248; -.
DR   KEGG; hsa:117248; -.
DR   MANE-Select; ENST00000339732.10; ENSP00000344260.5; NM_054110.5; NP_473451.3.
DR   UCSC; uc003car.5; human.
DR   CTD; 117248; -.
DR   DisGeNET; 117248; -.
DR   GeneCards; GALNT15; -.
DR   HGNC; HGNC:21531; GALNT15.
DR   HPA; ENSG00000131386; Tissue enhanced (adipose tissue, brain).
DR   MIM; 615131; gene.
DR   neXtProt; NX_Q8N3T1; -.
DR   OpenTargets; ENSG00000131386; -.
DR   PharmGKB; PA134936170; -.
DR   VEuPathDB; HostDB:ENSG00000131386; -.
DR   eggNOG; KOG3736; Eukaryota.
DR   GeneTree; ENSGT00940000160808; -.
DR   HOGENOM; CLU_013477_0_3_1; -.
DR   InParanoid; Q8N3T1; -.
DR   OMA; APERDWG; -.
DR   OrthoDB; 606683at2759; -.
DR   PhylomeDB; Q8N3T1; -.
DR   TreeFam; TF313267; -.
DR   PathwayCommons; Q8N3T1; -.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   SignaLink; Q8N3T1; -.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 117248; 6 hits in 1066 CRISPR screens.
DR   ChiTaRS; GALNT15; human.
DR   GeneWiki; GALNTL2; -.
DR   GenomeRNAi; 117248; -.
DR   Pharos; Q8N3T1; Tbio.
DR   PRO; PR:Q8N3T1; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q8N3T1; protein.
DR   Bgee; ENSG00000131386; Expressed in mucosa of stomach and 167 other tissues.
DR   ExpressionAtlas; Q8N3T1; baseline and differential.
DR   Genevisible; Q8N3T1; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030133; C:transport vesicle; IDA:LIFEdb.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IBA:GO_Central.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IBA:GO_Central.
DR   CDD; cd02510; pp-GalNAc-T; 1.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR045885; GalNAc-T.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond; Glycoprotein; Glycosyltransferase; Golgi apparatus; Lectin;
KW   Manganese; Membrane; Metal-binding; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..639
FT                   /note="Polypeptide N-acetylgalactosaminyltransferase 15"
FT                   /id="PRO_0000059137"
FT   TOPO_DOM        1..11
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        12..34
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        35..639
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          504..631
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   REGION          106..155
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          190..299
FT                   /note="Catalytic subdomain A"
FT   REGION          358..420
FT                   /note="Catalytic subdomain B"
FT   COMPBIAS        120..139
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         231
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         260
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         283
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         285
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         417
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        107
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        574
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        181..412
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        403..482
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        517..536
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        562..575
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        603..620
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   VARIANT         68
FT                   /note="V -> G (in dbSNP:rs36026882)"
FT                   /id="VAR_049243"
FT   VARIANT         151
FT                   /note="P -> L (in dbSNP:rs11715981)"
FT                   /id="VAR_049244"
FT   VARIANT         324
FT                   /note="P -> A (in dbSNP:rs12634179)"
FT                   /id="VAR_049245"
FT   VARIANT         432
FT                   /note="A -> T (in dbSNP:rs17851238)"
FT                   /evidence="ECO:0000269|PubMed:17974005, ECO:0000269|Ref.7"
FT                   /id="VAR_049246"
FT   VARIANT         510
FT                   /note="H -> Y (in dbSNP:rs2271077)"
FT                   /id="VAR_019593"
FT   CONFLICT        44
FT                   /note="V -> D (in Ref. 5; CAD38585)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        326
FT                   /note="K -> R (in Ref. 5; CAD89983)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   639 AA;  73063 MW;  F5DCA523AF4965DA CRC64;
     MLLRKRYRHR PCRLQFLLLL LMLGCVLMMV AMLHPPHHTL HQTVTAQASK HSPEARYRLD
     FGESQDWVLE AEDEGEEYSP LEGLPPFISL REDQLLVAVA LPQARRNQSQ GRRGGSYRLI
     KQPRRQDKEA PKRDWGADED GEVSEEEELT PFSLDPRGLQ EALSARIPLQ RALPEVRHPL
     CLQQHPQDSL PTASVILCFH DEAWSTLLRT VHSILDTVPR AFLKEIILVD DLSQQGQLKS
     ALSEYVARLE GVKLLRSNKR LGAIRARMLG ATRATGDVLV FMDAHCECHP GWLEPLLSRI
     AGDRSRVVSP VIDVIDWKTF QYYPSKDLQR GVLDWKLDFH WEPLPEHVRK ALQSPISPIR
     SPVVPGEVVA MDRHYFQNTG AYDSLMSLRG GENLELSFKA WLCGGSVEIL PCSRVGHIYQ
     NQDSHSPLDQ EATLRNRVRI AETWLGSFKE TFYKHSPEAF SLSKAEKPDC MERLQLQRRL
     GCRTFHWFLA NVYPELYPSE PRPSFSGKLH NTGLGLCADC QAEGDILGCP MVLAPCSDSR
     QQQYLQHTSR KEIHFGSPQH LCFAVRQEQV ILQNCTEEGL AIHQQHWDFQ ENGMIVHILS
     GKCMEAVVQE NNKDLYLRPC DGKARQQWRF DQINAVDER
//
